Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study
Open Access
- 19 February 2014
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 85 (10) , 1109-1115
Abstract
Objectives To identify MRI biomarkers associated with long-term disability progression in patients with multiple sclerosis (MS), and to define the rate of evolution of global, tissue-specific and regional atrophy in patients with MS over long-term. Methods MRI of the brain and clinical neurological assessment was performed in 81 patients at time of first visit and after 5 and 10 years of follow-up. MRI was acquired on 1.5 T scanners. T1-lesion and T2-lesion volumes (LVs) were calculated. Global and tissue-specific atrophy changes were longitudinally assessed, using a direct measurement approach, by calculating percentage volume changes between different time points. Regional tissue volumes for the subcortical deep grey matter (SDGM) structures were also obtained. Disability progression was defined as an increase in Expanded Disability Status Scale of ≥1.0 compared to baseline at 5-year and 10-year follow-up. Results Over 5 years, patients with disability progression showed significantly increased loss of whole brain (−3.8% vs −2.0%, pConclusion This long-term study shows that whole brain, cortical and putamen atrophy occurs throughout the 10-year follow-up of this MS cohort and is more pronounced in the group that showed disability progression at 5, but not at 10 years of follow-up. Overall, GM atrophy showed better association with disease progression than WM atrophy over 5-year and 10-year follow-up.Keywords
This publication has 45 references indexed in Scilit:
- Thalamic Atrophy Is Associated with Development of Clinically Definite Multiple SclerosisRadiology, 2013
- Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 YearsAmerican Journal of Neuroradiology, 2013
- Measurement and clinical effect of grey matter pathology in multiple sclerosisThe Lancet Neurology, 2012
- Meningeal and cortical grey matter pathology in multiple sclerosisBMC Neurology, 2012
- Postmortem verification of MS cortical lesion detection with 3D DIRNeurology, 2012
- Gray matter imaging in multiple sclerosis: what have we learned?BMC Neurology, 2011
- Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosisJournal of the Neurological Sciences, 2009
- Gray matter atrophy is related to long-term disability in multiple sclerosisAnnals of Neurology, 2008
- Grey matter pathology in multiple sclerosisActa Neurologica Scandinavica, 2006
- Eight-year follow-up study of brain atrophy in patients with MSNeurology, 2002